Mama-Match
MultiMedRx review
There is no medication price on this site. The $100 is "the $100 fully refundable consultation fee" and the "$45 to start" is an entry promotion; the program fee — the one that actually pays for the medication — is described in the FAQ and never stated. What it does say clearly is the billing period: the "(4-Week monthly) program fee", four weeks and monthly in the same phrase, which is thirteen charges a year rather than twelve. And if you ask about states, it sends you to the intake form.
- HSA / FSA eligible
- Independently scored
- No insurance needed
Every medical claim is cited to its primary source — the clinical trial or the FDA label — so you can open it and check it yourself. No one on this team is your healthcare professional. What follows is friendly information, never medical advice.
Gentler first steps than MultiMedRx
Providers we'd send a friend to, with the ones we work with listed first — CoreAge Rx leads our ranking on the score. Some of these links earn MamaGLP a referral commission.
- Meet CoreAge RxCoreAge RxOur #1 pick
$99/mo semaglutide, $149/mo tirzepatide, one flat price with both medications in a single account — and an intake that walks you through it instead of cornering you with a quiz.
- Meet Willow
$299/mo semaglutide, $399/mo tirzepatide, both public before any questionnaire, with a name and a face on every prescribing doctor — 36 states only, and the cost climbs with your dose.
- Meet Trimi Health
$175/mo semaglutide, $235/mo tirzepatide, flat and all-inclusive nationwide — the eye-catching $99 is the annual-prepay rate.
MultiMedRx at a glance
- Semaglutide
- No medication price published at all
- Tirzepatide
- No medication price published at all
- Coverage
- Refuses to publish it: "complete the patient intake form"
- Brand-name
- Compounded only
How we scored MultiMedRx
Each factor is judged from MultiMedRx's actual pricing, disclosures and support, then combined into the Mama-Match Score of 35/100 using the same weighted six-factor framework we apply to every provider — never influenced by whether a provider pays us.
The cost is unpredictable, hidden behind a quiz, or in the premium range.
Coverage is limited or gated behind a signup.
Canceling carries real friction — commitments, notice windows or non-refundable charges.
The start feels transactional — more cash register than welcome.
Little public detail about who oversees your care, and how.
Support is thin once the prescription ships.
How we verified this review
- Last reviewed
- August 2026
- Confidence
- Low
- Primary source
- multimedrx.com
Read from MultiMedRx's own pages in August 2026. It publishes no medication price at all: the $100 on its homepage is a fully refundable consultation fee and the "$45 to start" is an entry promotion, while the program fee that actually covers the medication is described but never stated. Its own FAQ calls it the "(4-Week monthly) program fee" — four weeks rather than a calendar month, so thirteen billing cycles a year — and says it covers medication up to 10ml of tirzepatide or 2.5ml of semaglutide. Asked which states it serves, the site says to complete the intake form. It publishes NPI numbers and two addresses but names no operating entity.
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $100 | Consultation fee only; no medication price published"Pay the $100 fully refundable consultation fee". This is NOT a medication price — the site never publishes one. |
| Compounded tirzepatide | $100 | Consultation fee only; no medication price publishedThe same refundable fee. It says the program fee covers "up to 10ml for Tirzepatide", without saying what that fee is. |
Swipe the table to see plan details →
HSA/FSA is usually accepted for GLP-1 telehealth — check your plan. Prices reflect what MultiMedRx disclosed publicly at our last review and change often; confirm the current number on MultiMedRx's site.
What we like
- The $100 consultation fee is described as fully refundable, and said up front
- It does say what the program fee covers: medication "up to 10ml for Tirzepatide and 2.5 for Semaglutide"
- "You don't need to sign a long-term contract", with a one-month option
- Publishes NPI numbers and two real addresses, in Newport Beach and Reno
- Offers metformin, testosterone and hormone therapy as well as the GLP-1s
The caveats
- No medication price appears anywhere: the program fee is described but never stated
- The $100 is a consultation fee and the $45 a promotion; neither is a monthly cost
- The billing period is four weeks, not a month — its own phrase is "(4-Week monthly) program fee", so thirteen cycles a year
- It refuses to publish coverage: "To find out if we're available in your state, simply complete the patient intake form"
- The included medication is capped by volume, so a high dose could use it up
- It names no operating entity
MultiMedRx for moms: our verdict
There is no medication price on this site. The $100 is "the $100 fully refundable consultation fee" and the "$45 to start" is an entry promotion; the program fee — the one that actually pays for the medication — is described in the FAQ and never stated. What it does say clearly is the billing period: the "(4-Week monthly) program fee", four weeks and monthly in the same phrase, which is thirteen charges a year rather than twelve. And if you ask about states, it sends you to the intake form.
We looked at MultiMedRx the way moms actually have to: not just the monthly cost, but the right timing around pregnancy and nursing and honest, clear pricing from the start — the parts a generic weight-loss review skips.
What MultiMedRx actually costs
- Compounded semaglutide — Consultation fee only; no medication price published: $100/4 weeks
- Compounded tirzepatide — Consultation fee only; no medication price published: $100/4 weeks
That price covers the consult. It does not cover the medication — that's billed separately.
The medications MultiMedRx prescribes
MultiMedRx prescribes semaglutide and tirzepatide — the two molecules with the strongest published weight-loss results, and having both on one account matters when insulin resistance (common with PCOS and after gestational diabetes) makes tirzepatide the better fit. These are compounded formulas from a licensed pharmacy — the reason the price stays low — but compounded GLP-1s are not FDA-approved finished products the way Wegovy and Zepbound are.
Where it operates. MultiMedRx lists its coverage as: Refuses to publish it: "complete the patient intake form".
Watch the cycle. MultiMedRx's advertised price buys 4 weeks, not a calendar month — over a year that's 13 refills, not 12.
Where MultiMedRx fits — and where it doesn't — for moms
A good fit if…
- you may need to switch between semaglutide and tirzepatide as your body and your hormones change.
Look elsewhere if…
- you specifically want an FDA-approved brand-name pen with its own pregnancy and breastfeeding label.
- you'd rather have a clinician talk the timing through with you, with the right timing around pregnancy and nursing in mind — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety and oversight
Our confidence here is limited — MultiMedRx publishes little about how its program actually works, so you're buying on price and on trust in its partners. As with any compounded GLP-1, the most useful thing moms can do is confirm which licensed pharmacy fills the prescription and what's in the formula — we explain how we score oversight in our scoring methodology.
One line that applies to every provider on this site: no GLP-1 is proven safe during pregnancy or breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the decision about timing is yours and your healthcare provider's.
The bottom line
MultiMedRx is a reasonable option — weigh it on the right timing around pregnancy and nursing and honest, clear pricing from the start against the alternatives below. For most moms, CoreAge Rx is still the best choice overall — see why it tops our ranking.
The bottom line
Best for: There is no way to say without a medication price, and the site does not give one.
Keep comparing MultiMedRx
Head-to-heads and alternatives
Ranked boards
- Best GLP-1 for moms — a gentle first step
- Best GLP-1 for women — PCOS, cycles, perimenopause
- Best GLP-1 for first-timers (easiest to start)
- Most affordable GLP-1 with honest, clear pricing
- Best semaglutide for mothers — price and practicality
- Best semaglutide for women — compounded vs brand
- Best semaglutide for young moms — postpartum and budget
- Best tirzepatide for mothers — is it worth the extra
- Best tirzepatide for women — PCOS and insulin resistance
- Best GLP-1 with bilingual / Spanish-language support
MultiMedRx, answered
- How much does MultiMedRx cost?
- MultiMedRx does not publish a standard monthly cash price — pricing depends on insurance or appears after a signup. Ask for a written quote and confirm the ongoing rate before you commit.
- Is MultiMedRx safe to use while breastfeeding?
- Here is the honest answer: no GLP-1 — compounded or brand-name — is established as safe during pregnancy or breastfeeding, and the labels advise against use; MultiMedRx is no exception. Plan any GLP-1 for after weaning, and talk the timing through with your own clinician.
- Does MultiMedRx offer both semaglutide and tirzepatide?
- Yes — MultiMedRx offers both. Tirzepatide's dual action is often preferred when insulin resistance is driving the weight, which matters with PCOS and after gestational diabetes.
- Where does MultiMedRx land in your ranking?
- MultiMedRx scores 35/100 on our Mama-Match Score (rank #303), which weights six things that matter to a first-timer. Our #1 pick, CoreAge Rx, leads the ranking — see how they compare.
Prices, states and verification reflect what MultiMedRx disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the published methodology. This is gentle background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.